Genus has announced its preliminary results for the first half of 2023, citing strong group performance, with group revenue rising by 10% in constant currency (16% in actual currency). The full report has been made available on the investors section of the Genus plc website.
“The group achieved a strong operational performance despite ongoing challenging market conditions for producers in several important markets. Revenues grew in all regions and both PIC and ABS delivered profit growth," said CEO Jorgen Kokke. "This also enabled us to deliver record adjusted EBITDA and good cashflow for the group. Growth in R&D investments, primarily due to the strategically important gene editing work and expansion of PIC’s elite farms, as well as higher interest costs, resulted in adjusted profit before tax consistent with the prior year."
Click here to see more...